CEO Today Healthcare Awards

www.ceotodaymagazine.com CEO Today Healthcare Awards 2019 32 Country FIRM PROFILE At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic diseases. Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic diseases: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 41,600 people in 80 countries and markets its products in more than 170 countries. The Novo Nordisk Way The Novo Nordisk Way is a set of guiding principles which underpins every decision we make. It describes who we are, how we work and what we want to achieve, and sets a clear direction for our company and our employees. Ultimately, it’s a promise we make to each other - and to the millions of patients all over the world who rely on our products to lead full and healthy lives. Novo Nordisk Way is our way In 1923, our Danish founders began a journey to change diabetes. Today, we are thousands of employees across the world with the passion, skills and commitment to drive change to defeat diabetes and other serious chronic diseases. • We aim to lead in all disease areas in which we are active. • Our key contribution is to discover and develop innovative biological medicines and make them accessible to patients throughout the world. • Growing our business and delivering competitive financial results is what allows us to help patients live better lives, offer an attractive return to our shareholders and contribute to our communities. • Our business philosophy is one of balancing financial, social and environmental considerations - we call it ‘The Triple Bottom Line’. • We are open and honest, ambitious and accountable, and treat everyone with respect. • We offer opportunities for our people to realise their potential. • We never compromise on quality and business ethics. Every day, we must make difficult choices, always keeping in mind, what is best for patients, our employees and our shareholders in the long run. It’s our way. It’s the Novo Nordisk Way. LARS FRUERGAARD JØRGENSEN CEO of Novo Nordisk DENMARK ABOUT LARS FRUERGAARD JØRGENSEN Lars Fruergaard Jørgensen joined Novo Nordisk in 1991 as an economist in Health Care, Economy&Planningandhasover the years completed overseas postings in the Netherlands, the US and Japan. In 2004 he was appointed senior vice president for IT & Corporate Development. In January 2013 he was appointed executive vice president and chief information officer assuming responsibility for IT, Quality & Corporate Development. In November 2014 he took over the responsibilities for Corporate People & Organisation and Business Assurance and became chief of staff. Mr Jørgensen was appointed president and chief executive officer in January 2017. Mr Jørgensen serves as vice- chair of the supervisory board and member of the nomination committee of Carlsberg A/S. Mr Jørgensen has an MSc in Finance and Business Administration from Aarhus School of Business, Aarhus University, Denmark, from 1991. Mr Jørgensen is a Danish national, born November 1966. www.novonordisk.com